Since we observed suppression of ovarian tumors by oral administration of PEITC, we hypothesized that growth inhibitory effects of PEITC in ovarian tumors in vivo were through inhibition of EGFR-AKT. The gene discussed is EGFR; the disease is ovarian neoplasm.